Instadose Pharma (Instadose Pharma) Receivables Turnover : 0.00 (As of Feb. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Instadose Pharma Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Instadose Pharma's Revenue for the three months ended in Feb. 2022 was $0.00 Mil. Instadose Pharma's average Accounts Receivable for the three months ended in Feb. 2022 was $0.00 Mil.

Instadose Pharma Receivables Turnover Historical Data

The historical data trend for Instadose Pharma's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Instadose Pharma Receivables Turnover Chart

Instadose Pharma Annual Data

Trend

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Receivables Turnover

Get a 7-Day Free Trial

Instadose Pharma Quarterly Data
	May17	Aug17	Nov17	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22
Receivables Turnover	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Instadose Pharma's Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Instadose Pharma's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Instadose Pharma's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Instadose Pharma's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Instadose Pharma's Receivables Turnover falls into.

Instadose Pharma Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Instadose Pharma's Receivables Turnover for the fiscal year that ended in Nov. 2021 is calculated as

	Receivables Turnover (A: Nov. 2021 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Nov. 2021 )	/ (	(Accounts Receivable (A: Nov. 2020 )	+	Accounts Receivable (A: Nov. 2021 ))	/	count )
=	0	/ (	(0	+	0)	/	1 )
=	0	/	0
=	N/A

Instadose Pharma's Receivables Turnover for the quarter that ended in Feb. 2022 is calculated as

	Receivables Turnover (Q: Feb. 2022 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Feb. 2022 )	/ (	(Accounts Receivable (Q: Nov. 2021 )	+	Accounts Receivable (Q: Feb. 2022 ))	/	count )
=	0	/ (	(0	+	0)	/	1 )
=	0	/	0
=	N/A

Instadose Pharma (OTCPK:INSD) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Instadose Pharma Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Instadose Pharma's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Instadose Pharma (Instadose Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Instadose Pharma Corp (OTCPK:INSD) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

5500 North Service Road, Suite 301, Burlington, ON, CAN, L7L 6W6

Website

https://www.instadosepharma.com

Instadose Pharma Corp, formerly Mikrocoze Inc is seeking to create a global distribution platform for medicinal cannabis and cannabinoid oil. The company endeavors to utilize the Global Distribution Platform to open the commercial gateway to a new wholesale marketplace along with providing pharmaceutical industry companies with large, sustainable, consistent, diverse, and low?cost supplies of high?quality medicinal cannabis and cannabinoid oil for use in bulk as an active pharmaceutical ingredient.